|
2020 Journal Article Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD)Brain, David, O'Beirne, James, Hickman, Ingrid J., Powell, Elizabeth E., Valery, Patricia C., Kularatna, Sanjeewa, Tulleners, Ruth, Farrington, Alison, Horsfall, Leigh and Barnett, Adrian (2020). Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD). BMC Health Services Research, 20 (1) 335, 335. doi: 10.1186/s12913-020-05233-2 |
|
2020 Journal Article Development and evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC)Valery, Patricia C, Bernardes, Christina M, Stuart, Katherine A, Hartel, Gunter F, McPhail, Steven M, Skoien, Richard, Rahman, Tony, Clark, Paul J, Horsfall, Leigh U, Hayward, Kelly L, Gupta, Rohit and Powell, Elizabeth E (2020). Development and evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC). Patient Preference and Adherence, 14, 599-611. doi: 10.2147/ppa.s236818 |
|
2020 Journal Article Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis: the shifting epidemiology of cirrhosisValery, Patricia C., McPhail, Steven, Stuart, Katherine A., Hartel, Gunter, Clark, Paul J., O'Beirne, James, Skoien, Richard, Rahman, Tony, Moser, Chris and Powell, Elizabeth E. (2020). Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis: the shifting epidemiology of cirrhosis. Internal Medicine Journal, 51 (5) imj.14809, 691-698. doi: 10.1111/imj.14809 |
|
2020 Journal Article Nonalcoholic fatty liver disease: interface between primary care and hepatology clinicsElangovan, Harendran, Rajagopaul, Sashen, Williams, Suzanne M., McKillen, Benjamin, Britton, Laurence, McPhail, Steven M., Horsfall, Leigh U., Valery, Patricia C., Hayward, Kelly L. and Powell, Elizabeth E. (2020). Nonalcoholic fatty liver disease: interface between primary care and hepatology clinics. Hepatology Communications, 4 (4) hep4.1486, 518-526. doi: 10.1002/hep4.1486 |
|
2020 Journal Article Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous AustraliansValery, Patricia C., Clark, Paul J., Pratt, Gregory, Bernardes, Christina M., Hartel, Gunter, Toombs, Maree, Irvine, Katharine M. and Powell, Elizabeth E. (2020). Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians. International Journal for Equity in Health, 19 (1) 27, 1-11. doi: 10.1186/s12939-020-1144-6 |
|
2020 Journal Article Unusual iron and copper studies in a patient with liver injury and normocytic anemiaRuddell, Richard G., Lee, Andrew, Powell, Elizabeth E., Wilgen, Urs and Ungerer, Jacobus P. J. (2020). Unusual iron and copper studies in a patient with liver injury and normocytic anemia. Clinical Chemistry, 66 (2), 277-281. doi: 10.1093/clinchem/hvz001 |
|
2019 Conference Publication Health-related quality of life in patients with cirrhosisAmarasena, S., Bernardes, C., Stuart, K., Gupta, R., Horsfall, L., Rahman, T., Clark, P., Skoien, R., Hartel, G., Hayward, K., Powell, E. and Valery, P. (2019). Health-related quality of life in patients with cirrhosis. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2020, Online, 21–30 November 2020. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/jgh.15269 |
|
2019 Conference Publication A time-dependent analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score and Fibrosis-4 score in patients with NAFLDMcKillen, B., Elangovan, H., Horsfall, L., Patel, P., Hayward, K., Clouston, A., Radford-Smith, D., Valery, P., Britton, L., Brown, N., Bernard, A. and Powell, E. (2019). A time-dependent analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score and Fibrosis-4 score in patients with NAFLD. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, SA Australia, 8–10 September 2019. Richmond, VIC Australia: Wiley-Blackwell. |
|
2019 Journal Article Clinically significant fibrosis is associated with longitudinal increases in fibrosis-4 and nonalcoholic fatty liver disease fibrosis scoresJanubhai Patel, Preya, Chieh-Yu Cheng, Johnson, Banh, Xuan, Gracen, Lucy, Radford-Smith, Daniel, Hossain, Fabrina, Horsfall, Leigh Ula, Lee Hayward, Kelly, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Stuart, Katherine Anne, Russell, Anthony William, Valery, Patricia Casarolli, Clouston, Andrew Donald, Irvine, Katharine Margaret, Bernard, Anne and Powell, Elizabeth Ellen (2019). Clinically significant fibrosis is associated with longitudinal increases in fibrosis-4 and nonalcoholic fatty liver disease fibrosis scores. Clinical Gastroenterology and Hepatology, 18 (3), 710-718.e4. doi: 10.1016/j.cgh.2019.07.036 |
|
2019 Journal Article ReplyHayward, Kelly L., Valery, Patricia C., Cottrell, W. Neil, Irvine, Katharine M., Martin, Jennifer H. and Powell, Elizabeth E. (2019). Reply. Hepatology Communications, 3 (9), 1283-1284. doi: 10.1002/hep4.1398 |
|
2019 Journal Article Contemporary educational interventions for general practitioners (GPs) in primary care settings in Australia: A systematic literature reviewBernardes, Christina Maresch, Ratnasekera, Isanka Umayangani, Kwon, Joo Hyun, Somasundaram, Sivagowri, Mitchell, Geoff, Shahid, Shaouli, Meiklejohn, Judith, Beirne, James O., Valery, Patricia Casarolli and Powell, Elizabeth (2019). Contemporary educational interventions for general practitioners (GPs) in primary care settings in Australia: A systematic literature review. Frontiers in Public Health, 7 (JUN) 176, 1-13. doi: 10.3389/fpubh.2019.00176 |
|
2019 Journal Article Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic Type 2 inflammationLoh, Zhixuan, Fitzsimmons, Rebecca L., Reid, Robert C., Ramnath, Divya, Clouston, Andrew, Gupta, Praveer K., Irvine, Katharine M., Powell, Elizabeth E., Schroder, Kate, Stow, Jennifer L., Sweet, Matthew J., Fairlie, David P. and Iyer, Abishek (2019). Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic Type 2 inflammation. British Journal of Pharmacology, 176 (19) bph.14768, 3775-3790. doi: 10.1111/bph.14768 |
|
2019 Journal Article Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosisYang, Yoon Mee, Noureddin, Mazen, Liu, Cheng, Ohashi, Koichiro, Kim, So Yeon, Ramnath, Divya, Powell, Elizabeth E., Sweet, Matthew J., Roh, Yoon Seok, Hsin, I-Fang, Deng, Nan, Liu, Zhenqiu, Liang, Jiurong, Mena, Edward, Shouhed, Daniel, Schwabe, Robert F., Jiang, Dianhua, Lu, Shelly C., Noble, Paul W. and Seki, Ekihiro (2019). Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis. Science Translational Medicine, 11 (496) eaat9284, eaat9284. doi: 10.1126/scitranslmed.aat9284 |
|
2019 Journal Article Engaging primary care clinicians in the assessment of NAFLDValery, Patricia C. and Powell, Elizabeth E. (2019). Engaging primary care clinicians in the assessment of NAFLD. Nature Reviews Gastroenterology and Hepatology, 16 (8), 458-460. doi: 10.1038/s41575-019-0164-4 |
|
2019 Journal Article Increasing hospitalization rates for cirrhosis: overrepresentation of disadvantaged AustraliansPowell, Elizabeth E., Skoien, Richard, Rahman, Tony, Clark, Paul J., O'Beirne, James, Hartel, Gunter, Stuart, Katherine A., McPhail, Steven M., Gupta, Rohit, Boyd, Peter and Valery, Patricia C. (2019). Increasing hospitalization rates for cirrhosis: overrepresentation of disadvantaged Australians. EClinicalMedicine, 11, 44-53. doi: 10.1016/j.eclinm.2019.05.007 |
|
2019 Conference Publication Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 InflammationIyer, Abishek, Loh, Zhixuan, Fitzsimmons, Rebecca L., Reid, Robert C., Ramnath, Divya, Clouston, Andrew, Irvine, Katharine M., Powell, Elizabeth E., Schroder, Kate, Stow, Jennifer L., Sweet, Matthew J. and Fairlie, David P. (2019). Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation. Experimental Biology Meeting (EB), Orlando Fl, Apr 06-09, 2019. HOBOKEN: WILEY. |
|
2019 Journal Article Medication‐related problems in outpatients with decompensated cirrhosis: Opportunities for harm preventionHayward, Kelly L., Patel, Preya J., Valery, Patricia C., Horsfall, Leigh U., Li, Catherine Y., Wright, Penny L., Tallis, Caroline J., Stuart, Katherine A., Irvine, Katharine M., Cottrell, W. Neil, Martin, Jennifer H. and Powell, Elizabeth E. (2019). Medication‐related problems in outpatients with decompensated cirrhosis: Opportunities for harm prevention. Hepatology Communications, 3 (5) hep4.1334, 620-631. doi: 10.1002/hep4.1334 |
|
2019 Journal Article Causes and consequences of innate immune dysfunction in cirrhosisIrvine, Katharine Margaret, Ratnasekera, Isanka, Powell, Elizabeth E. and Hume, David Arthur (2019). Causes and consequences of innate immune dysfunction in cirrhosis. Frontiers in Immunology, 10 (FEB) 293, 293. doi: 10.3389/fimmu.2019.00293 |
|
2019 Journal Article A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanismsSharkawy, Rasha El, Bayoumi, Ali, Metwally, Mayada, Mangia, Alessandra, Berg, Thomas, Romero-Gomez, Manuel, Abate, Maria Lorena, Irving, William L., Sheridan, David, Dore, Gregory J., Spengler, Ulrich, Lampertico, Pietro, Bugianesi, Elisabetta, Weltman, Martin, Mollison, Lindsay, Cheng, Wendy, Riordan, Stephen, Santoro, Rosanna, Gallego-Durán, Rocío, Fischer, Janett, Nattermann, Jacob, D’Ambrosio, Roberta, McLeod, Duncan, Powell, Elizabeth, latchoumanin, Olivier, Thabet, Khaled, Najim, Mustafa A. M., Douglas, Mark W., Liddle, Christopher ... Jonsson, Julie R. (2019). A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms. Scientific Reports, 9 (1) 1439, 1439. doi: 10.1038/s41598-018-35736-2 |
|
2019 Journal Article Corrigendum: Causes and consequences of innate immune dysfunction in cirrhosis (Frontiers in Immunology (2019) 10 (293) DOI: 10.3389/fimmu.2019.00293)Irvine, Katharine Margaret, Ratnasekera, Isanka, Powell, Elizabeth E. and Hume, David Arthur (2019). Corrigendum: Causes and consequences of innate immune dysfunction in cirrhosis (Frontiers in Immunology (2019) 10 (293) DOI: 10.3389/fimmu.2019.00293). Frontiers in Immunology, 10 (APR) 818, 818. doi: 10.3389/fimmu.2019.00818 |
